Latest News

Helsinn Group and MEI Pharma Discontinue the Phase 3 Study with Pracinostat in AML after Completing Interim Analysis
MEI Pharma to Present at the Jefferies Virtual Healthcare Conference
MEI Pharma to Host Investor and Analyst Video Webcast Following ASCO20 Virtual Scientific Program
MEI Pharma and Kyowa Kirin Announces ME-401 Phase 1b Study to be Highlighted in a Presentation at the Virtual Edition of the 25th European Hematology Association Annual Congress